BTMD Relative Valuation
BTMD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BTMD is overvalued; if below, it's undervalued.
Historical Valuation
Biote Corp (BTMD) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 3.96. The fair price of Biote Corp (BTMD) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：2.57
Fair
11.17
PE
1Y
3Y
5Y
Trailing
Forward
3.51
EV/EBITDA
Biote Corp. (BTMD) has a current EV/EBITDA of 3.51. The 5-year average EV/EBITDA is 2.28. The thresholds are as follows: Strongly Undervalued below -0.88, Undervalued between -0.88 and 0.70, Fairly Valued between 3.86 and 0.70, Overvalued between 3.86 and 5.44, and Strongly Overvalued above 5.44. The current Forward EV/EBITDA of 3.51 falls within the Historic Trend Line -Fairly Valued range.
5.28
EV/EBIT
Biote Corp. (BTMD) has a current EV/EBIT of 5.28. The 5-year average EV/EBIT is 3.20. The thresholds are as follows: Strongly Undervalued below -1.27, Undervalued between -1.27 and 0.97, Fairly Valued between 5.44 and 0.97, Overvalued between 5.44 and 7.68, and Strongly Overvalued above 7.68. The current Forward EV/EBIT of 5.28 falls within the Historic Trend Line -Fairly Valued range.
0.43
PS
Biote Corp. (BTMD) has a current PS of 0.43. The 5-year average PS is 0.53. The thresholds are as follows: Strongly Undervalued below -0.10, Undervalued between -0.10 and 0.22, Fairly Valued between 0.85 and 0.22, Overvalued between 0.85 and 1.17, and Strongly Overvalued above 1.17. The current Forward PS of 0.43 falls within the Historic Trend Line -Fairly Valued range.
2.80
P/OCF
Biote Corp. (BTMD) has a current P/OCF of 2.80. The 5-year average P/OCF is 2.77. The thresholds are as follows: Strongly Undervalued below -0.59, Undervalued between -0.59 and 1.09, Fairly Valued between 4.45 and 1.09, Overvalued between 4.45 and 6.13, and Strongly Overvalued above 6.13. The current Forward P/OCF of 2.80 falls within the Historic Trend Line -Fairly Valued range.
3.31
P/FCF
Biote Corp. (BTMD) has a current P/FCF of 3.31. The 5-year average P/FCF is 3.11. The thresholds are as follows: Strongly Undervalued below -0.39, Undervalued between -0.39 and 1.36, Fairly Valued between 4.86 and 1.36, Overvalued between 4.86 and 6.61, and Strongly Overvalued above 6.61. The current Forward P/FCF of 3.31 falls within the Historic Trend Line -Fairly Valued range.
Biote Corp (BTMD) has a current Price-to-Book (P/B) ratio of -1.09. Compared to its 3-year average P/B ratio of -2.56 , the current P/B ratio is approximately -57.52% higher. Relative to its 5-year average P/B ratio of -2.08, the current P/B ratio is about -47.79% higher. Biote Corp (BTMD) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 15.16%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 12.62% , the current FCF yield is about -100.00% lower.
-1.08
P/B
Median3y
-2.56
Median5y
-2.08
41.30
FCF Yield
Median3y
15.16
Median5y
12.62
Competitors Valuation Multiple
The average P/S ratio for BTMD's competitors is 0.00, providing a benchmark for relative valuation. Biote Corp Corp (BTMD) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -6.67%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BTMD decreased by 58.41% over the past 1 year. The primary factor behind the change was an decrease in Revenue Growth from 51.38M to 47.96M.
The secondary factor is the Margin Expansion, contributed -21.97%to the performance.
Overall, the performance of BTMD in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Biote Corp (BTMD) currently overvalued or undervalued?
What is Biote Corp (BTMD) fair value?
How does BTMD's valuation metrics compare to the industry average?
What is the current P/B ratio for Biote Corp (BTMD) as of Dec 05 2025?
What is the current FCF Yield for Biote Corp (BTMD) as of Dec 05 2025?
What is the current Forward P/E ratio for Biote Corp (BTMD) as of Dec 05 2025?